Noh, Hye-Ji
(HANILBIOMED Co.)
Cho, Hyang-Hyun (HANILBIOMED Co.) Kim, Hee-Kyong (HANILBIOMED Co.) Koh, Hong-Bum (College of Veterinary Medicine, Chonnam National University) |
1 | Brody, E. P. 2000. Biological activities of bovine glyco-macropeptide. British Journal of Nutrition. 84:S39-S46. |
2 | Boorman, G. A. et al. 2006. Pathology of the fischer rat. Academic Press, INC., pp.132-134. |
3 | Gikins, Mary L. A. 2006. Clinical laboratory parameters for Crl:CD (SD) rats. Charles River Laboratories. |
4 | Gorog, P. and Kovacs, I. B. 1978. Anti-inflammatory effect of sialic acid. Agents and Actions. 8:543-545. DOI |
5 | Iijima, R., Takahashi, H., Namme, R., Ikegami, S. and Yamazaki, M. 2004. Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Letters 561:163-166. DOI |
6 | Ishikawa, M. and Koizumi, S. 2010. Microbial production of N-acetylneuraminic acid by genetically engineered Escherichia coli. Carbohydrate Research 345:2605-2609. DOI |
7 | Keenan, C., Elmore, S., Francke-Carroll, S., Kemp, R., Kerlin, R., Peddada, S. and Pletcher, J. 2009. Best practices for use of historical control data of proliferative rodent lesions. Toxicol. Pathol. 37:679-693. DOI |
8 | Lewis, R. W., Billington, R., Debryune, E., Gamer, A., Lang, B. and Carpanini, F. 2002. Recognition of adverse and nonadverseeffects in toxicity studies. Toxicologic Pathology 30:66-74. DOI |
9 | Ministry of Food and Drug Safety (KFDA) Notice No. 2014-136 (Jul. 30, 2014) 'Guidelines for toxicity tests in drugs, etc.' KFDA Notice No. 2014-67 (Feb. 12, 2015). |
10 | Moon, Y. I., Lee, W. J. and Oh, S. 2005. Glycomacropeptide hydrolysed from bovine -casein: II. Chromatographic changes of -casein macropeptide as related to trichloroacetic acid concentration. Korean J. Food Sci. Ani. Resour. 17(1): 478-482. |
11 | Oh, S. J., Kim, S. H., Jeon, W. M., Kim, B. C. and Ki, Y. K. 1997. Glycomacropeptide hydrolysed from bovin -casein: I. The fractionation of glycomacropeptide. Korean J. Food Sci. Ani. Resour. 17(1):51-57. |
12 | Organization for Economic Co-operation and Development (OECD). 2008. OECD guidelines 408 for the testing of chemicals: Repeated Dose 90 day oral toxicity study in oodents Organization for Economic Co-operation and Development. Paris, France. pp.1-10. |
13 | Park, Y. C. and Cho, M. H. 2011. A new way in deciding NOAEL based on the findings from GLP-toxicity test. Toxicology Research 27:133-135. DOI |
14 | Wang, B. and Brand-Miller, J. 2003. The role and potential of sialic acid in human nutrition. European Journal of Clinical Nutrition. 57:1351-1369. DOI |
15 | Springer-Verlag, R. S. 1984. Sialic acids: Chemistry, metabolism and function. Carbohydrate Research 129:5-7. DOI |
16 | United States of Food and Drug Administration (USFDA). 2005. Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Pharmacology and Toxicology. United States of Food and Drug Administration. Rockville. MD, USA. pp.5-6. |
17 | Wang, B. 2009. Sialic acid is and essential nutrient for brain development and cognition. Annu. Rev. Nutr. 29:177-222. DOI |
18 | Wang, B., Brand-Miller, J., McVeagh, P. and Petocz, P. 2001. Concentration and distribution of sialic acid in human milk and infant formulas1-3. Am. J. Clin. Nutr. 74:510-515. DOI |
19 | Yoon, Y. C., Cho, J. K., Song, C. H., Lee, S. and Chung, C. I. 2000. Purification of the glycomacropeptide from cheese whey. Korean J. Food SCI. ANI. Resour. 20:159-165. |
20 | Wang, B., Yu, B., Karim, M., Hu, H. S., McGreevy, Y., Petocz, H. P., Held, S. and Miller, J. B. 2007. Dietary sialic acid supplementation improves learning and memory in piglets1-3. Am. J. Clin. Nutr. 85:561-569. DOI |
21 | Zimmermann, V., Hennemann, H. G., Daussmann, D. and Kragl, U. 2007. Modelling the reaction course of N-acetylneuraminic acid synthesis from N-acetyl-D-glucosamine new strategies for the optimisation of neuraminic acid synthesis. Appl. Microbiol. Biotechnol. 76:597-605. DOI |